Interestingly, these dysfunctions may be mitigated by TAAR1 ligands, as activation of TAAR1 by agonists has been shown to improve glycemic control and promote body weight in rodent models of obesity and diabetes. Here, TAAR1 is linked to obesity due to melanocortin 4 receptor deficiency.